Cabozantinib use in renal cell carcinoma

Neuwelt, AJ; Mathur, S; Johnson, AT; Kessler, ER; Bowles, DW

Bowles, DW (reprint author), Univ Colorado Denver, Div Med Oncol, 12801 East 17th Ave,MS 8117, Aurora, CO 80045 USA.

DRUGS OF TODAY, 2017; 53 (5): 299

Abstract

In the last several years, many new drugs have been approved to treat metastatic renal cell carcinoma (RCC). Cabozantinib is a novel multikinase inhib......

Full Text Link